• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Development of a prognostic score using the complete blood cell count for survival prediction in unselected critically ill patients.应用全血细胞计数开发一种预后评分,用于预测未经选择的危重症患者的生存情况。
Biomed Res Int. 2013;2013:105319. doi: 10.1155/2013/105319. Epub 2013 Feb 28.
2
The prognostic role of platelet to lymphocyte ratio and mean platelet volume in critically ill patients.血小板与淋巴细胞比值和平均血小板体积在危重症患者中的预后作用。
Eur Rev Med Pharmacol Sci. 2018 Apr;22(8):2246-2252. doi: 10.26355/eurrev_201804_14811.
3
Complete Blood Count Score Model Integrating Reduced Lymphocyte-Monocyte Ratio, Elevated Neutrophil-Lymphocyte Ratio, and Elevated Platelet-Lymphocyte Ratio Predicts Inferior Clinical Outcomes in Adult T-Lymphoblastic Lymphoma.完整血球计数评分模型整合了降低的淋巴细胞单核细胞比值、升高的中性粒细胞淋巴细胞比值和升高的血小板淋巴细胞比值,可预测成人 T 淋巴细胞白血病不良的临床结局。
Oncologist. 2019 Nov;24(11):e1123-e1131. doi: 10.1634/theoncologist.2018-0789. Epub 2019 Apr 5.
4
Prognostic value of neutrophil-lymphocyte ratio in critically ill patients with cancer: a propensity score matching study.中性粒细胞与淋巴细胞比值在癌症重症患者中的预后价值:一项倾向评分匹配研究
Clin Transl Oncol. 2021 Jan;23(1):139-147. doi: 10.1007/s12094-020-02405-8. Epub 2020 May 29.
5
The prognostic value of neutrophil-to-lymphocyte ratio on mortality in critically ill trauma patients.中性粒细胞与淋巴细胞比值对危重症创伤患者死亡率的预后价值。
J Trauma Acute Care Surg. 2016 Nov;81(5):882-888. doi: 10.1097/TA.0000000000000980.
6
Ratio of neutrophil to lymphocyte counts--rapid and simple parameter of systemic inflammation and stress in critically ill.中性粒细胞与淋巴细胞计数比值——危重症患者全身炎症和应激的快速简便指标。
Bratisl Lek Listy. 2001;102(1):5-14.
7
Red blood cell distribution width predicts long-term mortality in critically ill patients with acute kidney injury: a retrospective database study.红细胞分布宽度预测急性肾损伤危重症患者的长期死亡率:一项回顾性数据库研究。
Sci Rep. 2020 Mar 12;10(1):4563. doi: 10.1038/s41598-020-61516-y.
8
Prognostic value of neutrophil/lymphocyte ratio and mean platelet volume/platelet ratio for 1-year mortality in critically ill patients.中性粒细胞/淋巴细胞比值和血小板平均体积/血小板比值对危重症患者 1 年死亡率的预后价值。
Sci Rep. 2020 Dec 9;10(1):21513. doi: 10.1038/s41598-020-78476-y.
9
N-terminal pro-B-type natriuretic peptide is an independent predictor of outcome in an unselected cohort of critically ill patients.N 端前 B 型利钠肽是一组未经选择的危重症患者预后的独立预测指标。
Crit Care Med. 2007 Oct;35(10):2268-73. doi: 10.1097/01.CCM.0000284509.23439.5B.
10
[The prognostic value of serum procalcitonin on severity of illness in non-sepsis critically ill patients].[血清降钙素原对非脓毒症危重症患者病情严重程度的预后价值]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2016 Aug;28(8):688-93. doi: 10.3760/cma.j.issn.2095-4352.2016.08.004.

引用本文的文献

1
A grading system from health to death using routine experimental indicators based on the pre-chronic disease status theory.基于预慢病状态理论,使用常规实验指标对健康至死亡进行分级系统。
BMC Geriatr. 2020 Jul 20;20(1):250. doi: 10.1186/s12877-020-01653-1.
2
Estimating the survival advantage based on telomere length and serum biomarkers of aging.基于端粒长度和衰老血清生物标志物评估生存优势。
J Transl Med. 2017 Aug 1;15(1):166. doi: 10.1186/s12967-017-1267-8.
3
Extended leukocyte differential count and C-reactive protein in septic patients with liver impairment: diagnostic approach to evaluate sepsis in intensive care unit.肝功能损害的脓毒症患者的扩展白细胞分类计数及C反应蛋白:重症监护病房中评估脓毒症的诊断方法
Ann Transl Med. 2015 Oct;3(17):244. doi: 10.3978/j.issn.2305-5839.2015.09.41.

本文引用的文献

1
The DECAF Score: predicting hospital mortality in exacerbations of chronic obstructive pulmonary disease.DECAF 评分:预测慢性阻塞性肺疾病加重期的住院死亡率。
Thorax. 2012 Nov;67(11):970-6. doi: 10.1136/thoraxjnl-2012-202103. Epub 2012 Aug 15.
2
Absolute lymphocyte count at day 28 independently predicts event-free and overall survival in adults with newly diagnosed acute lymphoblastic leukemia.在新诊断的成人急性淋巴细胞白血病患者中,第 28 天的绝对淋巴细胞计数可独立预测无事件生存和总生存。
Am J Hematol. 2012 Oct;87(10):957-60. doi: 10.1002/ajh.23279. Epub 2012 Jun 22.
3
Factors predictive of 30-day postoperative mortality in HIV/AIDS patients in the era of highly active antiretroviral therapy.高效抗逆转录病毒治疗时代 HIV/AIDS 患者术后 30 天死亡率的预测因素。
Ann Surg. 2012 Jul;256(1):170-6. doi: 10.1097/SLA.0b013e318255896b.
4
Elevated neutrophil to lymphocyte ratio predicts poor prognosis in advanced colorectal cancer patients receiving oxaliplatin-based chemotherapy.中性粒细胞与淋巴细胞比值升高预示接受奥沙利铂为基础化疗的晚期结直肠癌患者预后不良。
Oncology. 2012;82(5):261-8. doi: 10.1159/000337228. Epub 2012 Apr 26.
5
Serum cortisol predicts death and critical disease independently of CRB-65 score in community-acquired pneumonia: a prospective observational cohort study.血清皮质醇可独立于 CRB-65 评分预测社区获得性肺炎患者的死亡和重症疾病:一项前瞻性观察性队列研究。
BMC Infect Dis. 2012 Apr 13;12:90. doi: 10.1186/1471-2334-12-90.
6
Absolute lymphocyte count at day + 21 predicts survival in patients with early-stage diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, adriamycin, vincristine and prednisone.在接受利妥昔单抗、环磷酰胺、阿霉素、长春新碱和泼尼松治疗的早期弥漫性大 B 细胞淋巴瘤患者中,第 21 天的绝对淋巴细胞计数可预测生存。
Leuk Lymphoma. 2012 Sep;53(9):1757-63. doi: 10.3109/10428194.2012.670231. Epub 2012 Apr 19.
7
Hematological changes as prognostic indicators of survival: similarities between Gottingen minipigs, humans, and other large animal models.血液学变化作为生存预后指标:格丁根小型猪、人类和其他大动物模型之间的相似性。
PLoS One. 2011;6(9):e25210. doi: 10.1371/journal.pone.0025210. Epub 2011 Sep 28.
8
Objective assessment of stress levels and health status using routinely measured clinical laboratory parameters as biomarkers.使用常规测量的临床实验室参数作为生物标志物来客观评估压力水平和健康状况。
Biomarkers. 2011 Sep;16(6):525-9. doi: 10.3109/1354750X.2011.606505. Epub 2011 Aug 19.
9
Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer.中性粒细胞/淋巴细胞比值可预测晚期结直肠癌患者的化疗结局。
Br J Cancer. 2011 Apr 12;104(8):1288-95. doi: 10.1038/bjc.2011.100. Epub 2011 Mar 29.
10
Validation of prognostic scores for survival in cancer patients beyond first-line therapy.验证预后评分在一线治疗后癌症患者生存中的应用。
BMC Cancer. 2011 Mar 15;11:95. doi: 10.1186/1471-2407-11-95.

应用全血细胞计数开发一种预后评分,用于预测未经选择的危重症患者的生存情况。

Development of a prognostic score using the complete blood cell count for survival prediction in unselected critically ill patients.

机构信息

Second Affiliated Hospital of Dalian Medical University, Dalian 116023, China.

出版信息

Biomed Res Int. 2013;2013:105319. doi: 10.1155/2013/105319. Epub 2013 Feb 28.

DOI:10.1155/2013/105319
PMID:23555073
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3600249/
Abstract

OBJECTIVE

The purpose of this study was to develop a new prognostic scoring system for critically ill patients using the simple complete blood cell count (CBC).

METHODS

CBC measurements in samples from 306 patients in an intensive care unit were conducted with automated analyzers, including levels of neutrophils, lymphocytes, erythrocytes, hemoglobin, and platelets. The time of sampling and the time of death were recorded. Z values were calculated according to the measured values, reference mean values, and standard deviations. The prognostic score was equivalent to the median of the Z value of each of the measured parameters.

RESULTS

There was a significant correlation between survival time and neutrophil, lymphocyte, and platelet levels (P < 0.05). Prognostic scores were calculated from the Z value of these three parameters. Survival times decreased as the prognostic score increased.

CONCLUSIONS

This study suggests that a model that uses levels of neutrophils, lymphocytes, and platelets is potentially useful in the objective evaluation of survival time or disease severity in unselected critically ill patients.

摘要

目的

本研究旨在使用简单的全血细胞计数(CBC)为危重症患者开发新的预后评分系统。

方法

使用自动分析仪对重症监护病房 306 名患者的样本进行 CBC 测量,包括中性粒细胞、淋巴细胞、红细胞、血红蛋白和血小板水平。记录采样时间和死亡时间。根据测量值、参考平均值和标准差计算 Z 值。预后评分等于每个测量参数的 Z 值的中位数。

结果

存活时间与中性粒细胞、淋巴细胞和血小板水平呈显著相关(P<0.05)。从这三个参数的 Z 值计算预后评分。随着预后评分的增加,存活时间减少。

结论

本研究表明,使用中性粒细胞、淋巴细胞和血小板水平的模型可能有助于客观评估未经选择的危重症患者的存活时间或疾病严重程度。